Wilms tumor

February 27, 2024

Multi-institutional study of Wilms tumor facilitates enrollment, optimizes treatment

Multi-institutional study finds that enrollment and outcomes were similar across racial and ethnic groups for children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide.

By Leigh MacMillan
April 6, 2021

Genetic differences in Wilms tumor

Unique somatic gene mutations may contribute to racial disparities in the incidence of Wilms tumor — the most common childhood kidney cancer.

By Leigh MacMillan
May 29, 2014

Exploring Wilms tumor race disparity

Unique molecular “fingerprints” could explain the disparity in Wilms tumor incidence and point to novel, race-specific therapeutic targets.

By Leigh MacMillan